{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:49:06Z","timestamp":1758818946723},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Through the implementation of systematic cervical cancer screening in the mid-20th century, the United States and other developed countries have seen death rates from cervical cancer decreased by \u226570%.The purpose of this article is to address several of the most controversial issues associated with cervical cancer screening recommendations in light of historical and evolving data. In this article, we will explore the controversies around the age at which to initiate and exit screening, human papilloma virus testing alone as a primary screening approach, and the impact of human papilloma virus vaccination on cervical cancer rates.<\/jats:p>","DOI":"10.1097\/grf.0000000000000478","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T13:37:01Z","timestamp":1562938621000},"page":"644-655","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Controversies in Cervical Cancer Screening"],"prefix":"10.1097","volume":"62","author":[{"given":"AMA","family":"BUS-KWOFIE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CATHERINE","family":"CHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RYAN","family":"KAHN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEVIN","family":"HOLCOMB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-20230911","first-page":"S2","article-title":"The impact of liquid-based cytology in decreasing the incidence of cervical cancer","volume":"4","author":"Gibb","year":"2011","journal-title":"Rev Obstet Gynecol"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/AOG.0b013e3181ac06e0","article-title":"ACOG Committee Opinion No. 436: evaluation and management of abnormal cervical cytology and histology in adolescents","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0b013e31826e4609","article-title":"Cervical carcinoma rates among young females in the United States","volume":"120","author":"Benard","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"R8-20230911","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ogc.2013.02.007","article-title":"Screening adolescents and young women","volume":"40","author":"Boardman","year":"2013","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9378(99)70256-5","article-title":"Risk factors for rapid-onset cervical cancer","volume":"180","author":"Hildesheim","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpag.2017.03.056","article-title":"Trends in cervical cancer screening in adolescents","volume":"30","author":"Vash-Margita","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R12-20230911","first-page":"1038","article-title":"Cervical cancer screening among women aged 18-30 years\u2014United States, 2000-2010","volume":"61","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2007.04.012","article-title":"Management of cervical intraepithelial neoplasia 2 in adolescent and young women","volume":"20","author":"Fuchs","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","year":"2018","journal-title":"JAMA"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2012.04.037","article-title":"Screening history preceding a diagnosis of cervical cancer in women age 65 and older","volume":"126","author":"Dinkelspiel","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1038\/sj.onc.1206629","article-title":"A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques","volume":"22","author":"Ziegert","year":"2003","journal-title":"Oncogene"},{"issue":"suppl 5","key":"R21-20230911","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R24-20230911","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL Randomized Clinical Trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1186\/s12885-015-1959-5","article-title":"Comparison of the Roche cobas\u00ae 4800 and Digene Hybrid Capture\u00ae 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial","volume":"15","author":"Cook","year":"2015","journal-title":"BMC Cancer"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.30454","article-title":"HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer","volume":"140","author":"Ogilvie","year":"2017","journal-title":"Int J Cancer"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2407-10-111","article-title":"A randomized controlled trial of human papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)","volume":"10","author":"Ogilvie","year":"2010","journal-title":"BMC Cancer"},{"key":"R29-20230911","first-page":"e95","article-title":"The budget impact of cervical cancer screening using HPV primary screening","volume":"22","author":"Wright","year":"2016","journal-title":"Am J Manag Care"},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.32067","article-title":"Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing","volume":"145","author":"Andreassen","year":"2018","journal-title":"Int J Cancer"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1007\/BF03405681","article-title":"Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis","volume":"104","author":"Racey","year":"2013","journal-title":"Can J Public Health"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1188\/06.CJON.559-560","article-title":"Gardasil: introducing the new human papillomavirus vaccine","volume":"10","author":"McLemore","year":"2006","journal-title":"Clin J Oncol Nurs"},{"key":"R35-20230911","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur J Cancer"},{"key":"R38-20230911","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamaoto.2015.3217","article-title":"Factors associated with mortality in pediatric vs adult nasopharyngeal carcinoma","volume":"142","author":"Richards","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/GCO.0000000000000241","article-title":"Global strategies for cervical cancer prevention","volume":"28","author":"Pimple","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10900-016-0284-5","article-title":"Variation in human papillomavirus vaccine uptake and acceptability between female and male adolescents and their caregivers","volume":"42","author":"Johnson","year":"2017","journal-title":"J Community Health"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1634\/theoncologist.2015-0119","article-title":"Exploring knowledge, attitudes, and practices related to breast and cervical cancers in Mongolia: aNational Population-Based Survey","volume":"20","author":"Yerramilli","year":"2015","journal-title":"Oncologist"},{"issue":"suppl 1","key":"R44-20230911","first-page":"9","article-title":"Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy","volume":"39","author":"Carrozzi","year":"2015","journal-title":"Epidemiol Prev"},{"key":"R45-20230911","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014\u2014United States","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R46-20230911","first-page":"625","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2013","volume":"63","author":"Elam-Evans","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.5888\/pcd14.160314","article-title":"Factors associated with parents\u2019 intent to vaccinate adolescents for human papillomavirus: findings from the 2014 National Immunization Survey-Teen","volume":"14","author":"Mohammed","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"R48-20230911","first-page":"252","article-title":"30 years of preventive studies of uterine cervical cancer 1982-2012","volume":"36","author":"Garrido","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"R49-20230911","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.amepre.2018.03.013","article-title":"Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction","volume":"55","author":"Guo","year":"2018","journal-title":"Am J Prev Med"},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"issue":"suppl 1","key":"R52-20230911","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/1471-2458-14-700","article-title":"Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis","volume":"14","author":"Ferrer","year":"2014","journal-title":"BMC Public Health"},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamapediatrics.2013.2752","article-title":"Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature","volume":"168","author":"Holman","year":"2014","journal-title":"JAMA Pediatr"},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1746-1561.2008.00306.x","article-title":"The HPV vaccine: framing the arguments FOR and AGAINST mandatory vaccination of all middle school girls","volume":"78","author":"Vamos","year":"2008","journal-title":"J Sch Health"},{"key":"R56-20230911","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1503\/cmaj.140900","article-title":"Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study","volume":"187","author":"Smith","year":"2015","journal-title":"CMAJ"},{"key":"R57-20230911","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13187-015-0791-6","article-title":"Health information seeking and cancer screening adherence rates","volume":"31","author":"Shneyderman","year":"2016","journal-title":"J Cancer Educ"},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"R59-20230911","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:17:19Z","timestamp":1694420239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000478","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}